GEMFIBROZIL in English translation

• gemfibrozil

Examples of using Gemfibrozil in Danish and their translations into English

Nedsat leverfunktion Gemfibrozil er kontraindiceret ved nedsat leverfunktion se pkt.
Hepatic impairment Gemfibrozil is contraindicated in hepatic impairment see section 4.3.

Amning Der foreligger ingen dokumentation for udskillelse af gemfibrozil i modermælk.
Lactation There are no data on excretion of gemfibrozil in milk.

Gemfibrozil kan også påvirke farmakokinetikken af simvastatin, lovastatin, pravastatin og rosuvastatin.
Gemfibrozil has also been reported to influence the pharmacokinetics of simvaststin, lovastatin, pravastatin and rosuvastatin.

Gemfibrozil øger HDL2
Gemfibrozil increases the HDL2

Hverken interaktionen med gemfibrozil eller clopidogrel kunne forudsiges på grundlag af cerivastatinets metabolisme.
Neither of the interactions with gemfibrozil or clopidogrel were predictable based on the metabolism of cerivastatin.

Gemfibrozil øger risikoen for myopati når det gives sammen med nogle HMG- CoA reduktasehæmmere.
Gemfibrozil increases the risk of myopathy when given concomitantly with some HMG-CoA reductase inhibitors.

fjernelse af kolesterol fra leveren øges af gemfibrozil.
removal of cholesterol from the liver is increased by gemfibrozil.

Da føde påvirker biotilgængeligheden en smule, bør gemfibrozil indtages 30 minutter før et måltid.
As the presence of food alters the bioavailability slightly gemfibrozil should be taken 30 minutes before a meal.

600 mg eller 900 mg gemfibrozil Hjælpestoffer se pkt.
600 mg or 900 mg gemfibrozil.

I overensstemmelse med resultaterne af in vitro forsøg hæmmes atorvastatins metabolisering via glucuronidering af gemfibrozil.
According to results of in vitro studies the metabolic pathway of atorvastatin via glucuronidation is inhibited by Gemfibrozil.

HDL- kolesterol efter gemfibrozil var 5, 71±2, 37 mg/ dl højere end efter simvastatin.
HDL cholesterol after gemfibrozil was 5.71±2.37 mg/ di higher than after simvastatin.

Biotransformation Gemfibrozil undergår oxidation af methylgruppen og danner efterhånden en hydroxymethyl- og en carboxylmetabolit. hovedmetabolitten.
Biotransformation Gemfibrozil undergoes oxidation of a ring methyl group to form successively a hydroxymethyl and a carboxyl metabolite the main metabolite.

I USA blev der i 1999 tilføjet en særlig kontraindikation til produktinformationen mod ordinering sammen med gemfibrozil.
In the US a specific contra-indication against co-prescription with gemfibrozil was added to product information in 1999.

For myopati% statin(med eller uden gemfibrozil)(antal sammenlignet med ikke- samtidig eksponerede) cerivastatin.
Of Myopathy% the last statin(with or without(No. exposed) gemfibrozil) compared to non-concurrent cerivastatin.

Brug hos patienter med galdestensdannelse Gemfibrozil kan øge kolesteroludskillelsen i galden, og dermed øge potentialet for galdestensdannelse.
Use in patients with gallstone formation Gemfibrozil may increase cholesterol excretion into the bile raising the potential for gallstone formation.

hovedsagelig som konjugater af gemfibrozil og dets metabolitter.
mainly as conjugates of gemfibrozil and its metabolites.

Gemfibrozil øger subfaktionerne HDL2
Gemfibrozil increases the high-density lipoproteins HDL2

Der var otte gange så stor risiko for myopati ved kombination af cerivastatin og gemfibrozil som ved monoterapi.
There was an 8-fold increased risk of myopathy when cerivastatin and gemfibrozil were taken concomitantly compared with monotherapy.

De amerikanske undersøgelser bekræfter, at der er øget risiko for myopati, når cerivastatin bruges i kombination med gemfibrozil.
The US studies confirm an increased risk of myopathy when cerivastatin was used in combination with gemfibrozil.

Bekymringen gik på en mulig øget risiko for rabdomyolyse i forbindelse med behandling med cerivastatin- navnlig kombineret med gemfibrozil.
There were concerns about a possibly increased risk of rhabdomyolysis associated with the use of cerivastatin- particularly in combination with gemfibrozil.